盐酸贝西沙星是一种新型的氟喹诺酮类抗菌药物，对盐酸贝西沙星的紫外吸收光谱（UV）、红外吸收光谱（IR）、质谱（MS）、核磁共振（NMR）波谱（包括1H NMR、13C NMR、DEPT、HSQC、HMBC、COSY和NOESY）数据进行了解析，对其所有的1H和13C NMR信号进行了归属，通过多种波谱学技术确证了盐酸贝西沙星的结构.
张明光
,
冯小虎
,
于水涛
,
吉小龙
,
陈再新
. 盐酸贝西沙星的波谱学数据与结构确证[J]. 波谱学杂志, 2018
, 35(3)
: 374
-384
.
DOI: 10.11938/cjmr20172609
The ultraviolet spectra (UV), infrared spectra (IR), mass spectra (MS) and nuclear magnetic resonance (NMR) spectra (i.e., 1H NMR, 13C NMR, DEPT, HSQC, HMBC, COSY and NOESY) of besifloxacin hydrochloride were acquired and interpreted. All 1H and 13C NMR signals were assigned, and the structure of the compound was determined.
[1] CHANG M H, FUNG H B. Besifloxacin:A topical fluoroquinolone for the treatment of bacterial conjunctivitis[J], Clin Ther, 2010, 32(3):454-471.
[2] 哈姆斯A E. 喹诺酮羧酸、其衍生物及它们的制备方法和作为抗菌剂的用途. 中国, 101595101A[P]. 2009-12-02.
[3] TOMISATO F K, YACHIYO A S, ABIKO H M, et al. Quilonone carboxylic acid derivatives:US, 005447926A[P]. 1995-09-05.
[4] 陈再新, 夏正君, 蒋龙, 等. 盐酸贝西沙星的制备方法. 中国, 102659761A[P]. 2012-09-12.
[5] WANG Y J, MA Z J. Synthesis of besifloxacin hydrochloride[J]. Hebei Huagong, 2011, 34(7):13-14. 王亚娟, 马志珺. 盐酸贝西沙星的合成[J]. 河北化工, 2011, 34(7):13-14
[6] 王立明, 郭夏, 宋雪梅. 盐酸贝西沙星制备新方法. 中国, 103058992A[P]. 2013-04-24.
[7] 田远. 一种盐酸贝西沙星的制备方法. 中国, 104592196A[P]. 2015-05-06.
[8] MALHOTRA R, ACKERMAN S, GEARINGER L S. The safety of besifloxacin ophthalmic suspension 0.6% used three times daily for 7 days in the treatment of bacterial conjunctivitis[J]. Drugs R D, 2013, 13(4):243-252.
[9] SUN W, GAO X, GUO J, et al. An NMR study on lomustine[J]. Chinese J Magn Reson, 2016, 33(2):353-359. 孙伟, 高翔, 郭娟, 等. 洛莫司汀的1H、13C NMR全归属[J]. 波谱学杂志, 2016, 33(2):353-359.
[10] YU D H, KANG W, HAO F, et al. Spectroscopic studies and structural elucidation of cabazitaxel[J]. Chinese J Magn Reson, 2017, 34(2):191-199. 余大海, 康旺, 郝福, 等. 卡巴他赛结构确证的波谱学研究[J]. 波谱学杂志, 2017, 34(2):191-199.
[11] YASASWINI P, VIJAYA L M, SAI S M, et al. Development and validation of new RP-HPLC-PDA method for the estimation of besifloxacin hydrochloride in pharmaceutical dosage forms[J]. Indo American Journal of Pharmaceutical Research, 2015, 5(11):3406-3411.
